Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gallbladder Metastasis from Renal Cell Carcinoma.
Kawahara T, Ohshiro H, Sekiguchi Z, Furuya M, Namura K, Itoh H, Sano F, Kawaji K, Hayashi N, Makiyama K, Nakaigawa N, Ogawa T, Uemura H, Yao M, Kubota Y. Kawahara T, et al. Among authors: namura k. Case Rep Oncol. 2010 Jan 29;3(1):30-34. doi: 10.1159/000279308. Case Rep Oncol. 2010. PMID: 20740155 Free PMC article.
Primary Synovial Sarcoma of the Kidney.
Kawahara T, Sekiguchi Z, Makiyama K, Nakayama T, Nagashima Y, Kita K, Namura K, Itou H, Sano F, Hayashi N, Nakaigawa N, Ogawa T, Uemura H, Yao M, Kubota Y. Kawahara T, et al. Among authors: namura k. Case Rep Oncol. 2009 Oct 14;2(3):189-193. doi: 10.1159/000245926. Case Rep Oncol. 2009. PMID: 20737036 Free PMC article.
Neuroendocrine Carcinoma of the Bladder.
Kawahara T, Yamanaka S, Ohshiro H, Sekiguchi Z, Namura K, Itou H, Sano F, Kita K, Hayashi N, Makiyama K, Nakaigawa N, Ogawa T, Uemura H, Yao M, Kubota Y. Kawahara T, et al. Among authors: namura k. Case Rep Oncol. 2010 Mar 3;3(1):54-58. doi: 10.1159/000289584. Case Rep Oncol. 2010. PMID: 20740160 Free PMC article.
Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report.
Tokita T, Kawahara T, Ito Y, Tsutsumi S, Abe K, Namura K, Sano F, Shioi K, Takamoto D, Yumura Y, Nakaigawa N, Yao M, Uemura H, Wada H, Tsuura Y, Kobayashi K. Tokita T, et al. Among authors: namura k. Urol Case Rep. 2018 Mar 13;18:54-56. doi: 10.1016/j.eucr.2018.03.006. eCollection 2018 May. Urol Case Rep. 2018. PMID: 29785370 Free PMC article.
Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K, Minamimoto R, Yao M, Makiyama K, Murakami T, Sano F, Hayashi N, Tateishi U, Ishigaki H, Kishida T, Miura T, Kobayashi K, Noguchi S, Inoue T, Kubota Y, Nakaigawa N. Namura K, et al. BMC Cancer. 2010 Dec 3;10:667. doi: 10.1186/1471-2407-10-667. BMC Cancer. 2010. PMID: 21129184 Free PMC article.
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Kakizoe M, Yao M, Tateishi U, Minamimoto R, Ueno D, Namura K, Makiyama K, Hayashi N, Sano F, Kishida T, Kobayashi K, Noguchi S, Ikeda I, Ohgo Y, Taguri M, Morita S, Inoue T, Kubota Y, Nakaigawa N. Kakizoe M, et al. Among authors: namura k. BMC Cancer. 2014 Jun 2;14:390. doi: 10.1186/1471-2407-14-390. BMC Cancer. 2014. PMID: 24885730 Free PMC article.
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.
Nakaigawa N, Kondo K, Tateishi U, Minamimoto R, Kaneta T, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Kubota Y, Inoue T, Yao M. Nakaigawa N, et al. Among authors: namura k. BMC Cancer. 2016 Feb 8;16:67. doi: 10.1186/s12885-016-2097-4. BMC Cancer. 2016. PMID: 26857818 Free PMC article.
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Ito H, Kondo K, Kawahara T, Kaneta T, Tateishi U, Ueno D, Namura K, Kobayashi K, Miyoshi Y, Yumura Y, Makiyama K, Hayashi N, Hasumi H, Osaka K, Yokomizo Y, Teranishi JI, Hattori Y, Inoue T, Uemura H, Yao M, Nakaigawa N. Ito H, et al. Among authors: namura k. Cancer Chemother Pharmacol. 2017 May;79(5):855-861. doi: 10.1007/s00280-017-3275-z. Epub 2017 Mar 22. Cancer Chemother Pharmacol. 2017. PMID: 28331985
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Nakaigawa N, Kondo K, Kaneta T, Tateishi U, Minamimoto R, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Hayashi N, Osaka K, Muraoka K, Izumi K, Kawahara T, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Inoue T, Yao M. Nakaigawa N, et al. Among authors: namura k. Cancer Chemother Pharmacol. 2018 Apr;81(4):739-744. doi: 10.1007/s00280-018-3542-7. Epub 2018 Feb 20. Cancer Chemother Pharmacol. 2018. PMID: 29464355
52 results